Dr. Parviz Kavoussi is named as a 2017 Texas Monthly Super Doctor
Dr. Kavoussi is named as a Texas Monthly Magazine Super Doctor for the 6th consecutive year. These handful of physicians are selected based on peer recognition, professional achievement, and disciplinary history. Doctors from each specialty with the highest scores from each group are invited to serve on a blue ribbon panel to evaluate the candidates […]
Dr. Shahryar Kavoussi speaks at the Infertility session at the PCS Global Obstetrics and Gynaecology Congress-2017 in Rome, Italy
Dr. Shahryar Kavoussi was invited to speak at the PCS Global Obstetrics and Gynaecology Congress-2017 in Rome, Italy. The congress took place from July 8th through July 9th, and his presentation was an update on the topic of AMH as a predictor of IVF outcomes. “The presentation that I gave at the meeting was an […]
A Family’s Success Story with Robotic Vasectomy Reversal
As one of the top leaders in robot assisted microsurgical vasectomy reversal, Dr. Parviz Kavoussi was interviewed regarding the procedure and a couple shared their success story. Mr. Nash underwent a robotic vasectomy reversal and he and his wife have had two children and are considering having a third. This demonstrates the durability of robotic […]
2017 Yelp Award Winner
At Austin Fertility Reproductive Medicine & Westlake IVF (AFRM), we’re honored to be presented with the 2017 Yelp Award. This award recognizes and celebrates local businesses that have “earned the love of customers”. Drs. Shahryar Kavoussi and Parviz Kavoussi exclaim, “There’s nothing more rewarding than hearing from patients themselves that we’ve made a difference in […]
Treating Low Testosterone that Safely Preserves Male Fertility
The Primed Southwest annual conference was held in Houston, TX this year. This multi-topic primary care conference updates primary care physicians on important topics in medicine. Dr. Parviz Kavoussi was invited to speak as a guest lecturer at the 2017 Primed conference. He spoke on the topic of hypogonadism, also known as low testosterone. As […]
Embryo Freezing has Improved Significantly Over the Years
The main goal of embryo freezing is to cryopreserve the embryo for later use. The first successful pregnancy that resulted from freezing a woman’s embryos was in the early 1980s. Since then, the factors in the IVF laboratory, including culture media, the ability to grow embryos in vitro to the blastocyst stage at day 5 […]
Dr. Parviz Kavoussi Lectures on Surgical Technique that Removes Tumor & Retrieves Sperm Simultaneously
Congenital adrenal hyperplasia (CAH) is the most common genetic disorder of steroid production affecting male fertility. One in every 16,000 individuals has classic CAH, which makes it one of the most common autosomal recessive human genetic diseases. Due to a disruption in the steroid producing pathway, men with CAH have an overproduction of steroid hormones […]
Male Fertility Testing Using a Smart Phone
CNN reports a new technology that will determine a man’s fertility through an app on a smartphone. While the technology is still in development by two Massachusetts hospitals, it has the potential to make infertility evaluation simpler and less costly. The app will be able to assess sperm count and motility with 98% accuracy. However, the […]
FAQ: How is the “best” embryo selected for transfer?
The “best” embryo for transfer is typically selected based on morphology (grading) and/or preimplantation genetic screening (PGS). Morphologic grading of cleavage-stage embryos (Day 2 and 3 embryos) involves the cell count and “fragmentation” rate of cells. Morphologic grading of blastocyst-stage embryos (Day 5 and 6 embryos) involves assessment of a group of cells that line the […]
Male Fertility Awareness
Fertility is often approached from a female point of view, even though it takes both healthy eggs and sperm to make a baby. Much of the emphasis on fertility is approached from the woman’s perspective. This is because a woman must not only play her part in fertilization, she must also carry the baby to […]
